04/03/2025
10:00 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
5:10 AM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
03/21/2025
4:20 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2025
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 424B4 | |
01/27/2025
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
01/15/2025
3:31 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
01/08/2025
3:11 PM | Panis Jaydriane (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/07/2025
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
3:47 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/30/2024
3:05 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VRPX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/18/2024
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:15 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
4:29 PM | Virpax Pharmaceuticals (Filer)
| Form DEF 14A | |
11/29/2024
5:39 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
4:01 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:31 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
5:06 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
4:20 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
11:15 PM | Virpax Pharmaceuticals (Filer)
| Form EFFECT | |
11/07/2024
4:01 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/28/2024
3:08 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/18/2024
4:28 PM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
10/10/2024
4:07 PM | Virpax Pharmaceuticals (Filer)
| Form 10-K/A | |
10/10/2024
4:08 PM | Virpax Pharmaceuticals (Filer)
| Form 10-K/A | |
10/09/2024
4:00 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K/A | |
10/04/2024
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:12 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
8:05 AM | Virpax Pharmaceuticals (Filer)
| Form S-1/A | |
08/13/2024
6:35 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:26 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
3:30 PM | Virpax Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/26/2024
3:31 PM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
6:45 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
5:40 PM | Su Judy (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/15/2024
7:00 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:09 PM | Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
3:10 PM | Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
11:48 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
3:00 PM | Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Post-Halving = Profit Season (Here’s How to Win It) (Ad) It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential.
We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks.
Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap.
And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it. The Most Profitable Phase of Crypto Just Started - PLUS Claim your $10 in Bitcoin |
07/09/2024
3:01 PM | Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/09/2024
3:02 PM | Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:03 PM | Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:32 PM | Virpax Pharmaceuticals (Filer)
| Form DEFA14A | |
07/08/2024
6:30 AM | Virpax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free VRPX Stock Alerts